| Authors: |
Lanman TA; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Neurology, University of Washington, Seattle, WA, USA., Gross H; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Faria CM; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Miller JJ; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Cahill DP; Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Mass General Brigham, Boston, MA, USA., Shih HA; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Mass General Brigham, Boston, MA, 02114, USA., Zarrella GV; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Neurology, Division of Neuro-Oncology, Virginia Commonwealth University, Richmond, VA, USA., Dietrich J; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Parsons MW; Pappas Center for Neuro-Oncology, Mass General Brigham, Boston, MA, USA. mwparsons@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mwparsons@mgh.harvard.edu. |
